Sima, A.A., Zhang, W., Li, Z.G., Murakawa, Y. and Pierson, C.R. (2004) Molecular Alterations Underlie Nodal and Paranodal Degeneration in Type 1 Diabetic Neuropathy and Are Prevented by C-Peptide. Diabetes, 53, 1556-1563.
http://www.ncbi.nlm.nih.gov/pubmed/15161761

has been cited by the following article:

• TITLE: Diabetes Mellitus and Diabetic Peripheral Neuropathy

  AUTHORS: Lídia Karla Martinho Bruschi, Dayvson Araújo da Rocha, Eusínio Lavigne Gesteira Filho, Nathália de Moura Pancoti Barboza, Poliana Aparecida Bresciane Frisanco, Raquel Milanesi Callegaro, Larissa Bianca Paiva Cunha de Sá, Alberto Krayyem Arbex

  KEYWORDS: Diabetes mellitus, Diabetic Peripheral Neuropathy, Diabetic Foot, Diabetes and Complications

  JOURNAL NAME: Open Journal of Endocrine and Metabolic Diseases, Vol.7 No.1, January 5, 2017

  ABSTRACT: Diabetes mellitus (DM) is considered a major public health problem because of its high prevalence and progressive increase of incidence. DM chronic complications are major causes of morbidity and mortality, among which diabetic neuropathy (DN) stands out, affecting 30% - 50% of DM patients. An appropriate medical approach, involving anamnesis and thorough clinical examination, is extremely important for the early diagnosis of DN and, therefore, to the prevention of its complications, including the amputation of limbs. Despite of the importance of DN prevention and treatment, in order to provide improved quality of life and longevity to DM patients, current therapeutic options are very limited with respect to both symptom control and as effective disease therapies. Intensive glucose control is extremely important in order to prevent and avoid the progression of DN, as demonstrated in two large multicenter studies involving patients with type 1 DM, the DCCT (Diabetes Control and Complications Trial) and the EDIC (Epidemiology of Diabetes Interventions and Complications).